AlphaYouML
Insider buying
Mark Lappe bought $2.6M of Inhibrx Biosciences, Inc. (INBX) stock
Mark Lappe, Chief Executive Officer of Inhibrx Biosciences, Inc. (INBX), bought 25,000 shares of INBX stock worth $2.6M, per an SEC Form 4 filed Sep 8, 2026.
It was an open-market purchase.
The trade was reported on Sep 8, 2026.
INBX has moved -2.0% since the trade date, from $114.34 to $112.04 (Sep 21, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 8, 2026
- Filing delay
- 0 days
- Price since
- -2.0%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More INBX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.